Gene Editing Longitudinal and proteome-wide analysis of antibodies in COVID-19 patients using a SARS-CoV-2 proteome microarray Posted on May 2, 2022 by Editorial Staff The first longitudinal proteome-wide analysis of antibodies in COVID-19 patients has been performed by researchers from the Beijing Institute of Microbiology and Epidemiology and published in the Journal of Advanced Research. Share on FacebookTweetFollow us Editorial Staff The generation of SARS-CoV-2 virus-like particles in insect cells Neutralizing antibodies produced following COVID-19 BNT162b2 vaccine found to activate complement cascade